
News|Articles|May 1, 2008
FDA Pipeline preview, May 2008
Recent FDA action (through May 2008) related to ceftobiprole, sugammadex, romiplostim, Gardasil, and amrubicin.
Advertisement
Approvable designation
Recommended for approval
Priority review
Orphan drug designation
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
4
A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors
5
































